700 filings, 70 countries: How this small-cap pharma stock is building its growth engine
- Posted on September 15, 2026
- By Financial Express
- 0 Views
- 1 min read
In brief
Generating AI summary…
700 filings, 70 countries: How this small-cap pharma stock is building its growth engine
Six manufacturing units, 700-plus regulatory filings, biosimilar clinical trials underway and a revenue model built on one principle: each new registration can potentially contribute USD 1.5 to 2 million in annual revenue. The potential compounding from that model is what has driven the stock and what investors need to understand before drawing conclusions about the current price.
